| Catalog | name | Description | price | 
|---|---|---|---|
| R-C-1842 | H3B-6527 CAS:1702259-66-2 | H3B-6527 is a highly selective covalent FGFR4 inhibitor with an IC50 value of <1.2 nM and at least 250-fold selectivity over FGFR1-3(IC50 values of 320,1,290 and 1,060nM respectively). | price> | 
| R-C-1845 | SGI7079 CAS:1239875-86-5 | SGI-7079,a novel selective Axl inhibitor with an IC50 of 58 nM in vitro, inhibits tumor growth in a dose dependent manner and is a potential therapeutic target for overcoming EGFR inhibitor resistance. | price> | 
| R-C-1853 | DBPR114 CAS:2443767-35-7 | DBPR114 is a potent multi-kinase inhibitor with potent activities against more than 57 oncogenic kinases,including Aurora-A,FLT3,CSF1R,MET,etc.DBPR114 exhibited favorable PK profiles:a long half-life(t1/2 =23.5h),moderate clearance and high volume of distribution.Also DBPR114 can effectively inhibit the growth of human acute myeloid leukemia MOLM-13 and MV4-11,MIA PaCa-2,Hep3B, MKN45,Colo205,and NTUB1 solid tumor xenografts in vivo without causing significant body weight loss. | price> | 
| R-C-1863 | Vecabrutinib (SNS-062) CAS:1510829-06-7 | Vecabrutinib(SNS-062)is a potent,noncovalent BTK and ITK inhibitor, with Kd values of 0.3 nM and 2.2nM,respectively.Vecabrutinib shows an IC50 of 24 nM for ITK. | price> | 
| R-C-1864 | BAY 61-3606 CAS:732983-37-8 | BAY 61-3606 is an orally available,ATP-competitive,reversible and highly selective Syk inhibitor with a Ki of 7.5nM and an IC50 of 10nM.BAY 61-3606 reduces ERK1/2 and Akt phosphorylation in neuroblastoma cell.BAY 61-3606 induces a large decrease of Syk phosphorylation in K-rn cell lysates.Bay 61-3606 sensitizes TRAIL-induced apoptosis by downregulating Mcl-1 in breast cancer cells. | price> | 
| R-C-1868 | PRT-060318(PRT318) CAS:1194961-19-7 | PRT-060318(PRT318)is a novel selective inhibitor of the tyrosine kinase Syk with an IC50 of 4nM. | price> | 
| R-C-1882 | Evobrutinib (M-2951) CAS:1415823-73-2 | Evobrutinib(M-2951,MSC-2364447C)is a highly selective BTK inhibitor with an IC50 of 37.9 nM.It has potential anti-neoplastic activity. | price> | 
| R-C-2254 | LM22B-10 CAS:342777-54-2 | LM22B-10 is a TrkB and TrkC agonist.LM22B-10 exhibits neurotrophic activity . | price> | 
| R-C-1909 | AD 80 CAS:1384071-99-1 | AD80,a multikinase inhibitor,shows strong activity against human RET(c-RET),BRAF,S6K,and SRC but were much less active than either AD57 or AD58 against mTOR.The IC50 value for RET is 4nM. | price> | 
| R-C-1931 | EHT5372 CAS :1425945-63-6 | EHT 5372 is a highly potent and selective inhibitor of DYRK isfamily kinases with IC50s of 0.22,0.28,10.8,93.2,22.8,88.8,59.0,7.44,221 nM for DYRK1A,DYRK1B,DYRK2,DYRK3,CLK1,CLK2,CLK4,GSK-3α,GSK-3β. | price> | 

Items-$0.00

Email:
Tel.:
                    RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
                
                    Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China 
                
                    Tel:  02988811435
                
                    Fax: (86-29)8881-1435
                
                    Email: sales@ruixibiotech.com
                
                    Web: http://www.ruixibiotech.com    
					
							
                

